a need for continued research with immunotherapy in small cell lung cancer: 2022 esmo florida
Published 1 year ago • 160 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
0:39
opportunities for potential cure in non-metastatic non-small cell lung cancer: 2022 esmo florida
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
1:18
incorporating immunotherapy in cervical cancer and endometrial cancer treatment: 2022 esmo florida
-
0:54
expanding treatment choices and immunotherapy in non-melanoma skin cancers: 2022 esmo florida
-
0:51
“moving the needle” in the metastatic breast cancer setting: 2022 esmo florida
-
0:36
esmo 2019 daily reporter - editor's picks: lung cancer
-
7:00
expert report on neoadjuvant immune checkpoint inhibitors for nsclc
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
1:06
lung cancer highlights from esmo 2022
-
1:56
lung cancer research at esmo 2021
-
10:25
esmo 2017: unmet needs in lung cancer patients | fiona blackhall
-
3:49
update from esmo 2024: immunotherapy (io) for hcc
-
2:30
#esmo22 highlights on first-line atezolizumab in nsclc not eligible for platinum: the ipsos study
-
4:17
nsclc trial updates at esmo 2022: adaura, destiny-lung02, kn189, kn407 & poseidon
-
21:04
2022 west oncology conference | lung cancers | metastatic session
-
5:50
#esmo21 expert video report on novelties in metastatic nsclc
-
15:57
2021 west oncology | lung cancer | updates on immunotherapy and small cell lung cancer stage 4
-
1:52
esmo 2022 highlights in head and neck cancer